Tekla Life Sciences Investors Financial Ratios — HQL Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Return on Common Equity (%)	- -	6.09	-16.41	28.38	12.82	-22.71	5.59	19.8	17.59
Return on Assets (%)	- -	6.05	-16.29	28.25	12.67	-22.05	5.47	19.76	17.54
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	98.2	96.12	101.64	99.17	98.24	101.31	95.02	98.4	99.08
Profit Margin (%)	98.2	96.12	101.64	99.17	98.24	101.31	95.02	98.4	99.08
Net Income to Common Margin (%)	98.2	96.12	101.64	99.17	98.24	101.31	95.02	98.4	99.08
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	36.96
Sustainable Growth Rate (%)	- -	6.09	-16.41	28.38	12.82	-22.71	5.59	19.8	11.09

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	99.58	99.38	99.14	99.88	97.99	95.94	99.83	99.81	99.67
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt to Equity	-0.13	- -	-0.29	- -	- -	- -	- -	- -	-0.01
Net Debt/Capital (%)	-0.13	- -	-0.29	- -	- -	- -	- -	- -	-0.01
EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Cash Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -
Current Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -
Quick Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Avg Current Liab	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	99.58	99.38	99.14	99.88	97.99	95.94	99.83	99.81	99.67
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Total Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	1,837.05
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	140.45	92.67	63.01	423.89	29.17	12.29	300.6	286.05	159.96

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Market Capitalization	463	458	350	420	513	351	334	423	459
- Cash & Cash Equivalents	1	- -	1	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Capital	466	475	384	484	523	398	402	460	514
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	459	476	334	419	505	335	353	423	476
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	70	30	-69	124	66	-103	24	87	86
TTM EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	32
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	32

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	15.01
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Low Price	15.85	18.01	13.95	11.45	16.6	13.03	12.25	11.34	10.55
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	6.69	16.6	- -	3.41	7.82	- -	15.78	4.96	5.56
Price/Earnings Average	6.04	16	-5.28	3.29	7.58	-3.96	17.64	4.51	4.84
Price/Earnings High	6.93	18.08	-6.48	3.74	8.53	-5.08	19.37	5.23	5.56
Price/Earnings Low	4.94	14.64	-4.37	2.22	6.24	-3.06	15.51	3.73	3.78
Price/Book Value	0.99	0.96	0.91	0.87	0.98	0.88	0.83	0.92	0.89
Price/Book Value Average	0.9	0.93	1.02	0.84	0.95	1.09	0.93	0.84	0.78
Price/Book Value High	1.03	1.05	1.25	0.95	1.07	1.4	1.02	0.97	0.89
Price/Book Value Low	0.73	0.85	0.84	0.57	0.78	0.84	0.82	0.69	0.61
Price/Tangible Book Value	0.99	0.96	0.91	0.87	0.98	0.88	0.83	0.92	0.89
Price/Tangible Book Value Average	0.9	0.93	1.02	0.84	0.95	1.09	0.93	0.84	0.78
Price/Tangible Book Value High	1.03	1.05	1.25	0.95	1.07	1.4	1.02	0.97	0.89
Price/Tangible Book Value Low	0.73	0.85	0.84	0.57	0.78	0.84	0.82	0.69	0.61
Price/Sales	6.57	15.96	-4.81	3.38	7.68	-3.25	15	4.88	5.51
Price/Sales Average	5.93	15.38	-5.36	3.26	7.45	-4.01	16.76	4.44	4.8
Price/Sales High	6.8	17.38	-6.59	3.71	8.38	-5.15	18.4	5.15	5.51
Price/Sales Low	4.85	14.07	-4.44	2.2	6.13	-3.1	14.73	3.67	3.75
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	15.01
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	13.07
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	15.02
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	10.21
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	13.07
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	15.02
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	10.21
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Last Price	21.48	20.42	15.1	17.58	20.8	13.66	12.47	15.08	15.51
High Price	22.23	22.24	20.68	19.28	22.7	21.64	15.3	15.9	15.52
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -

Shares Outstanding	22	22	23	24	25	26	27	28	30
Diluted Weighted Avg Shares	21	23	22	24	24	25	28	28	31
Basic Weighted Avg Shares	21	23	22	24	24	25	28	28	31
Revenue per Share	3.27	1.28	-3.14	5.2	2.71	-4.2	0.83	3.09	2.82
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	3.21	1.23	-3.19	5.16	2.66	-4.26	0.79	3.04	2.79
Basic EPS from Cont Ops	3.21	1.23	-3.19	5.16	2.66	-4.26	0.79	3.04	2.79
Diluted EPS, GAAP	3.21	1.23	-3.19	5.16	2.66	-4.26	0.79	3.04	2.79
Diluted EPS from Cont Ops	3.21	1.23	-3.19	5.16	2.66	-4.26	0.79	3.04	2.79
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	1.03
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	1.03
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	1.03
Cash & Equivalents per Share	0.03	- -	0.05	- -	- -	- -	- -	- -	- -
Book Value per Share	21.62	21.22	16.55	20.25	21.22	15.49	15	16.38	17.35
Tangible Book Value per Share	21.62	21.22	16.55	20.25	21.22	15.49	15	16.38	17.35

Tekla Life Sciences Investors

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)